Literature DB >> 8539550

Bacteraemia due to Escherichia coli in a Danish university hospital, 1986-1990.

B Olesen1, H J Kolmos, F Orskov, I Orskov, A Gottschau.   

Abstract

433 episodes of E. coli bactereaemia over a 5-year period in a Danish university hospital were studied with special emphasis on possible differences between nosocomial (NO) and community-acquired (CA) cases. Data from 186 males and 247 females with ages ranging from 9 days to 94 years were recorded. The average incidence of E. coli bacteraemia was 24.4 episodes/10,000 admissions/year. Older females accounted for the largest number of cases, which reflected the composition of the background population. The highest risk of infection was in males 80-89 years of age. The highest frequency of NO infections was in the departments of Intensive Care (90%) Orthopaedic Surgery (87%) and Haematology (80%). The most common focus was the urinary tract, with 72% of the episodes with a known focus, while the biliary tract was the focus in 14%. NO bacteraemia was independently related to immunosuppressive therapy, presence of predisposing factors, polymicrobial bacteraemia and presence of a non-urinary tract focus. A urinary tract focus was associated with CA bacteraemia, monomicrobial infection, female sex and a normal or elevated total white blood cell count. Patients with NO bacteraemia had predisposing factors more often than had CA patients, especially haematological malignancies and immunosuppressive therapy. Lack of a known bacterial focus was more common in NO than CA episodes, particularly among patients with haematologic malignancies. The overall mortality was 21%. Increased mortality was independently related to leukopenia (45%), immunosuppressive therapy and NO bacteraemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539550     DOI: 10.3109/00365549509019018

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients.

Authors:  Jonas Marschall; Lixin Zhang; Betsy Foxman; David K Warren; Jeffrey P Henderson
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

2.  Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia.

Authors:  Jose A Martínez; Sara Soto; Anna Fabrega; Manel Almela; Josep Mensa; Alex Soriano; Francesc Marco; María T Jimenez de Anta; Jordi Vila
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors.

Authors:  Andreas Reisner; Karen A Krogfelt; Bjarke M Klein; Ellen L Zechner; Søren Molin
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

4.  Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points.

Authors:  Kerri A Thom; Michelle D Shardell; Regina B Osih; Marin L Schweizer; Jon P Furuno; Eli N Perencevich; Jessina C McGregor; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2008-11       Impact factor: 3.254

Review 5.  Sexual dimorphism in bacterial infections.

Authors:  Edgar Ricardo Vázquez-Martínez; Elizabeth García-Gómez; Ignacio Camacho-Arroyo; Bertha González-Pedrajo
Journal:  Biol Sex Differ       Date:  2018-06-20       Impact factor: 5.027

6.  Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.

Authors:  Kerri A Thom; Marin L Schweizer; Regina B Osih; Jessina C McGregor; Jon P Furuno; Eli N Perencevich; Anthony D Harris
Journal:  BMC Infect Dis       Date:  2008-09-15       Impact factor: 3.090

7.  Population-based incidence and comparative demographics of community-associated and healthcare-associated Escherichia coli bloodstream infection in Auckland, New Zealand, 2005-2011.

Authors:  Deborah A Williamson; Alwin Lim; Siouxsie Wiles; Sally A Roberts; Joshua T Freeman
Journal:  BMC Infect Dis       Date:  2013-08-21       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.